Coverage will end completely for patients who purchase their plans from the Massachusetts Health Connector or those who are insured through a workplace with 99 or fewer employees
With all thr media attention, rest assured, your BOP and the FDA is going to be watching Hi Collin, I'm curious to hear your thoughts on the long-term implications of this news for the digital health industry
Under federal law, specifically Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies are generally prohibited from producing copies of commercially available, FDA-approved drugs
The coating-protected method of Smartamine is based on the pH differences between the rumen and abomasum, and the release of the AA will depend on the environmental pH
doi: 10.1016/j.neuron.2018.11.018
For most compounds the headline safety question is what are the side effects? For 5-Amino-1MQ the honest headline is we do not yet know, and the correct response to not-knowing is conservatism documented doses, scheduled breaks, and a licensed clinician in the loop rather than assuming the absence of reported effects means the absence of risk